Cyprotex Highlights - October 2022
In our blog this month we cover two new pieces of research:
- Building on the collaborative work with Unilever, read about our recent joint publication: 'Are Non-animal Systemic Safety Assessments Protective? A Toolbox and Workflow'
- Learn more about our poster presented at the 2022 AAPS PharmSci 360 conference in Boston on developing a high throughput screening platform for identifying inhibitors and activators of CYP46A1 - a key enzyme in cholesterol metabolism
Announcing the 5th edition of our ever-popular ADME Guide!
Here at Cyprotex we work hard to keep our educational guides up to date. Download the most recent update of our ADME Guide as well as the current editions of our DDI Regulatory guide and Mechanisms of Drug Induced Toxicity Guide for free by following the link below:
Join our experts Masaaki Yatsu and Tim Potter in Yokohama, Japan, for the 37th Annual Meeting of the Japanese Society for the Study of Xenobiotics.
Read the latest news from parent company, Evotec:
- Florence Séjourné appointed as Chief Executive Officer of Evotec joint venture Aurobac Therapeutics
- Evotec and TIAP expand upon their LAB150 BRIDGE partnership to include Amgen as a strategic partner
- Evotec launches PanHunter, the PanOmics data analysis platform, as a software-as-a-service (“SaaS”) product at Bio-IT World
- Evotec joins forces with Hannover Medical School to create a molecular patient database in autoimmune diseases
Read more from Evotec, Cyprotex and Just - Evotec Biologics in the Science Pool blog:
.jpeg)
Telephone:
Europe: +44 (0)1625 505100
North America (East Coast): +1-888-297-7683
Email:
info@evotec.eu